blood tests (B12, HbA1c, thyroid) for metabolic causes
Hereditary hemochromatosis-a new look at an old disease
Medicaid Coverage of and Spending on GLP-1s GLP-1 (glucagon-like peptide-1) drugs were originally developed to help people with type 2 diabetes manage blood sugar levels but have gained widespread attention for their effectiveness as a treatment for obesity
However, when GLP-1 receptor agonists are used in combination with insulin or sulphonylureas, the risk of hypoglycaemia increases, and dose reduction of these agents may be necessary
Other studies have shown that general weight gain may increase insulin insensitivity, especially on diabetes type 1 patients
Best GLP-1 Tracker for Health Management 2025 In 2025, the best GLP-1 tracker is more than an app, it's a precision health co-pilot